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Introduction
Purpura Fulminans (PF), also known 
as Purpura Gangrenosa, is a fulminant and 
devastating disease, usually of children. 
Three forms of PF are described:
• Idiopathic Purpura Fulminans
• associated with the post infectious period of a 
benign disease, most commonly seen during 
recovery from chicken pox or strep
• Acute Infectious Purpura Fulminans
• associated with severe sepsis, usually with 
meningococcemia or streptococcemia.
• Neonatal Purpura Fulminans
• due to congenital clotting factor deficiencies.
In PF, clotting factor deficiencies in conjunction with 
disseminated intravascular coagulopathy (DIC) 
lead to:
• Intravascular occlusion with micro-thrombi and a 
hemorrhagic vasculitis.
• Cutaneous and visceral ecchymosis and edema
• Ischemia, gangrene and shock.
Typical lesions:
• symmetrical ecchymoses on the extremities (lower predominate) and buttocks.  
• The lesions are painful and progress to necrosis, hemorrhagic blebs and gangrene. 
Introduction- M&M
PF has a high mortality rate, variously reported as 
13,36,44 or 90%.  Significant morbidity occurs in 
almost all patients given the high rate of 
amputations and invalidity.
• One series (n=70) reported amputations to all
extremities in 25%. 
• In another 3/9 died and 5/6 of the survivors had at 
least 2 amputations 
• Disfiguring facial involvement occurs frequently  
Introduction- Treatment
Treatments for this disease include: 
• Heparin/low molecular weight Heparin
• fresh frozen plasma 
• empiric antibiotics covering MRSA, Neisseria 
and streptococcal species 
• low molecular weight dextran 
• steroids. 
• In deficiency states, antithrombin III and protein 
C concentrates are given 
• Intra-arterial thrombolysis has been utilized as 
well as sympathectomy or regional anesthesia to 
reduce vasospasm 
• Often require fasciotomy for compartment 
syndrome and excision of gangrenous areas to 
prevent invasive sepsis 
Case Report
A previously healthy, 43 year old male with an 
apparent flu-like illness precipitously declined the day 
following the onset of symptoms.  He developed:  
• Pneumococcal Sepsis
• Renal Failure With Anuria
• Shock With Brief PEA Arrest
• Disseminated Intravascular Coagulation (DIC)
• Purpura Fulminans (PF)
He required one week of aggressive care before being 
stable enough to consider HBOT.  He required 
continuous renal replacement therapy, antibiotics, 
blood products and ventilator support.
Case Report- HBOT
His initial course of HBOT was complicated by 
upper airway infection (viral stomatitis) & marked 
confusion.  
He required intubation for airway control and to 
decrease the work of breathing.   He tolerated a t-
piece better than our simplistic chamber ventilator 
(Sechrist 500a).
Case Report- Outcome
• He received 17 HBO treatments in total 
• (twice daily at first) done at only 2.0 ATA as we 
were unable to give air breaks on T-piece.
• Transcutaneous oximetry was not done but may have 
aided in determining an endpoint to HBOT.
• Marked reduction of purpuric, ischemic appearing 
tissue with good demarcation of blackened tissue to 
the distal digits.
40 days out
Case Report- Outcome
Adjunctive HBOT treatment spared much at 
risk tissue. 
At one month follow up it was apparent that he 
would need some distal amputation of his digits 
but, he would have good function of all 
proximal joints including thumbs and great 
toes.   
His renal function was improving- He would not 
require long-term dialysis.  
Long term: He refused a right foot amputation 
and deals with chronic osteomyelitis in that 
foot.  Otherwise he is high functioning with 
family and employment.
Review of Literature
• A Medline search was done using the key words 
purpura fulminans and gangrenosa in 
conjunction with hyperbaric oxygen. 
• Fifteen case report papers were identified, with 
only 19 total patients with purpura fulminans
treated with HBOT 
• An additional unpublished report was found that 
noted six children who did well with early and 
aggressive HBOT (Personal communication, P. 
Allinson). 
• No controlled studies were found to exist. 
Hyperbaric oxygen appeared to be of value in most of 
the reported cases, and the degree of improvement 
appears to be associated with the timeliness as well 
as the aggressiveness of the treatments. 
Aggressive treatment started within 24 hours- did well 
in both short- and long term, with only some minor 
distal digital amputations necessary
Those treated late (five- to 10 days post-onset of PF) 
had more variable results. Two out of five required 
below-the-knee amputation, and another required 
multiple debridement and skin grafting. A fourth patient 
had minor digit loss. 

Discussion
Hyperbaric oxygen appears to ameliorate the 
complications of purpura fulminans by:
• reducing edema 
• increasing local tissue oxygenation via increased 
partial pressures and increased diffusion 
distance
• attenuating reperfusion injury and platelet 
aggregation
• enhancing leukocyte-killing activity
• capillary and fibroblast proliferation and collagen 
production 
In addition, HBOT may provide benefit by 
increasing red blood cell (RBC) deformation, 
allowing RBCs to perfuse areas that they otherwise 
could not due to capillary and small arteriolar 
damage from the purpura fulminans or from 
impaired RBC deformability contributing to sludging
and inability to offload oxygen through the capillary 
Hyperbaric oxygen appears to be useful in other 
purpuric eruptions such as Henoch-Schonlein
purpura and thrombotic thrombocytopenic purpura, 
likely by the same mechanisms
Discussion
Conclusions
1. Multiple reports emphasize the use of early and 
aggressive hyperbaric oxygen in purpura fulminans
balancing its utility against issues of hemodynamic 
instability and potential pulmonary oxygen toxicity. 
2. Transcutaneous oximetry may be useful in 
determining an endpoint to treatment with 
hyperbaric oxygen.
3. Although a randomized controlled study is fairly 
infeasible, a retrospective case-controlled study 
comparing cases treated with and without 
hyperbaric oxygen may better define the 
usefulness of HBO2 for purpura fulminans as well 
as clarify the issues of early versus late treatment 
and the utility of aggressive therapy. 
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